Boehringer Ingelheim Vetmedica, Inc.
3902 Gene Field Road
St. Joseph, Missouri 64506
- Phone 866-638-2226
- Fax 816-326-9167
ToDay® treats gram-positive and gram-negative bacteria in lactating dairy cows. Using a convenient, single-day treatment, ToDAY saves producers time and money when solving problems related to mastitis.
New studies from leading mastitis researchers have confirmed what we’ve known all along: Two treatments are as effective as five when treating mastitis.
Considering the cost of discarded milk, the dollars spent on mastitis tubes, and the crowding of your hospital pen, mastitis treatment could be costing you a lot more than it should. When it comes to mastitis treatment, two truly is equal to five.
A Non-Inferiority Trial Comparing a First Generation Cephalosporin with a Third-Generation Cephalosporin in the Treatment of Non-Severe Clinical Mastitis in Dairy Cows.
Minimum Inhibitory Concentrations (MIC) for cephalosporin compounds on their active metabolites for selected mastitis pathogens.
Randomized Non-Inferiority Clinical Trial Evaluating Three Commercial Dry Cow Mastitis Preparations.
ToDAY should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.
ToDay® uses cephapirin sodium to treat susceptible gram-positive and gram-negative organisms, including penicillin-resistant Strep agalactiae and Staph aureus. It is for use in lactating dairy cows and treatment is accomplished in a single day, saving producers time and money when treating mastitis.